Cycles may become shorter, longer, heavier, lighter, more irregular, or temporarily absent
In related news, Pfizer recently announced that it was dropping development work on a weight loss drug while continuing work on another
Clinical trials are now proving the efficacy of these molecules in treating cardiovascular disease, chronic kidney disease, sleep apnea, and even neurodegenerative conditions like Alzheimers
The 2mg starting dose was well tolerated in the trial, with gastrointestinal effects -- nausea, diarrhea -- most common at higher doses
According to altRx: "altRx patients typically experience 1-2 lbs per week weight loss after 4 weeks, combined with a healthy diet and exercise." The company further qualifies this statement with: "Based on average weight loss reported by patients without diabetes who reached and maintained a dose of 2.4 mg/week of GLP-1 treatment, alongside reduced calorie intake and increased physical activity." And the brand's qualifying language continues: "Results vary based on starting weight and program adherence
After three months, Schweppe lost 35 pounds while taking Semaglutide with a healthy diet and exercise
